摘要
人类辅助生殖技术(assisted reproductive technology,ART)是运用医学技术和方法对配子、合子、胚胎进行人工操作,以达到受孕目的的技术。为加强医疗质量安全管理,保障接受ART治疗患者助孕期间及妊娠期的安全,北京市人类辅助生殖技术质量控制和改进中心结合国家卫生健康委员会印发的孕产妇妊娠风险评估与管理工作规范(孕产妇妊娠风险评估五色球管理),拟定本标准及其使用建议。本评估方法通过对接受辅助生殖治疗的女性进行妊娠相关风险的筛查、评估和管理,及时发现并干预相关风险因素,防范不良妊娠结局,保障母婴安全。
Assisted reproductive technology(ART)is a medical procedure that involves manual manipulation of gametes,zygotes,and embryos to achieve successful pregnancy.In order to enhance the management of medical quality and safety during ART treatment as well as patient prognosis,the Expert Group for Beijing Human Assisted Reproductive Technology Center for Quality Control and Improvement collaborated with the National Health Commission of the People's Republic of China to establish standardized guidelines for Maternal Pregnancy Risk Assessment and Management.These guidelines employ a five-color ball system to evaluate maternal pregnancy risk levels among patients undergoing ART therapy,accompanied by recommendations on their implementation.The method aims to screen,evaluate,and manage pregnancy-related risks in women undergoing assisted reproductive treatment,while promptly identify and address risk factors,prevent adverse pregnancy outcomes,and ensure the safety of both mother and infant.
作者
辅助生殖助孕患者妊娠风险评估标准及使用建议编写组
李蓉
杨蕊
陈立雪
潘宁宁
尚䴖
周雯慧
陈亮
孙正怡
韩红敬
马延敏
耿琳琳
王颖
杨晓葵
赵连明
王慧春
吴红萍
乔杰
Expert Group for Evaluation Criteria and Usage Recommendations for Pregnancy Risk in Assisted Reproductive Techonology;Li Rong(不详;Center for Reproductive Medicine,Department of Obstetrics and Gynecology,Peking University Third Hospital,National Clinical Research Center for Obstetrics and Gynecology,Beijing Human Assisted Reproductive Technology Centre for Quality Control and Improvement)
出处
《中华生殖与避孕杂志》
CAS
CSCD
北大核心
2024年第7期668-678,共11页
Chinese Journal of Reproduction and Contraception
关键词
生殖技术
辅助
妊娠风险评估
专家建议
Reproductive technology,assisted
Pregnancy risk assessment
Expert recommendations
